1. How effective is the magnetic vascular embolic agent in enhancing the therapeutic efficacy of radiofrequency ablation and vascular embolization for hepatocellular carcinoma?
  2. What is the mechanism behind the inhibition of lactic acid production by the released Zn2+ from the magnetic vascular embolic agent, and how does it alleviate the anaerobic glycolysis-associated immunological inhibition?
  3. Can the combination of Thrombin-ZnTA-Fe3O4-PFP and anti-programmed cell death protein-1 antibody immune checkpoint blockade be applied to other types of cancer with distant metastases
用英文对下面的研究提几个问题:AbstractAims Radiofrequency ablation RFA is clinically adopted to destroy hepatocellular carcinoma but is often incapable of completely ablating large tumors and those with multiple met

原文地址: https://www.cveoy.top/t/topic/gA7k 著作权归作者所有。请勿转载和采集!

免费AI点我,无需注册和登录